Sunshine Biopharma, Inc. (SBFM) Tops Q3 EPS by 2c

Sunshine Biopharma, Inc. (NASDAQ: SBFM) reported Q3 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $5.96 million versus the consensus estimate of $6 million.

For earnings history and earnings-related data on Sunshine Biopharma, Inc. (SBFM) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Morgan Stanley course-corrects their semiconductor equipment outlook on demand
• ICICI Securities Resumes Dalmia Bharat Ltd (DALBHARA:IN) at Add (2)